
Atomic Show #314 – Economies of scale for micro, small, medium, large reactors – with James Krellenstein
James Krellenstein is a physicist, consultant and nuclear energy historian. He is currently employed as a senior advisor to Global Health Strategies. He started up their decarbonization practice with an emphasis on nuclear energy along with renewables. He was the lead author on GEH’s report on ways to reduce global dependence on Russia for necessary…

Why did the Carbon Free Power Project get cancelled? What does that mean for NuScale?
I’ll start with a disclosure. I’m still long on NuScale in my personal portfolio and have no intention of changing that position in the near future. I believe that the company has a…

Atomic Show #313 – Stefano Buono, Founder and CEO of Newcleo
Stefano Buono is a physicist and the successful founder of Advanced Accelerator Applications, a multibillion dollar company that pioneered the use of several therapeutic medical isotopes. After making several people very rich, including…

Parnassus Versus Green Century: A Contrast in Styles
Cross-posted from Nucleation Capital June, July and August of 2023 were the three hottest months the Earth has ever seen by such a large margin, it left climate scientists agog. Climate disasters are…

Unnecessary rules should be eliminated
Commissioners on the Nuclear Regulatory Commission are worried. They see a pending avalanche of license applications for new reactors, fuel production facilities, uranium mines, transportation containers, and waste repositories with an insufficiently sized…

Atomic Show #314 – Economies of scale for micro, small, medium, large reactors – with James Krellenstein
James Krellenstein is a physicist, consultant and nuclear energy historian. He is currently employed as a senior advisor to Global Health Strategies. He started up their decarbonization practice with an emphasis on nuclear…

Atomic Show #313 – Stefano Buono, Founder and CEO of Newcleo
Stefano Buono is a physicist and the successful founder of Advanced Accelerator Applications, a multibillion dollar company that pioneered the use of several therapeutic medical isotopes. After making several people very rich, including…

Atomic Show #312 – Tyler Bernstein, CEO Zeno Power
Zeno Power makes cost-effective radioisotope power systems (RPS) for some of the most challenging environments in the solar system. Its systems use a proprietary package that allows a wider variety of isotopes to…
Prefab Reactors For Off-Grid Users
At the top of Mt. Washington, New Hampshire, for example, electricity for the weather station is provided by a diesel generator using fuel that must be moved by small tanker trucks struggling up…
Pronuclear videos continuing to proliferate – The Nuclear Option
With a hat tip to Ben Heard at Decarbonize SA, I thought it might inspire you to see two videos side by side. These videos were created in geographic locations that are about…
Atomic Show #277 – Simon Wakter, pro-nuclear engineer in an ambivalent country
Simon Wakter is a strongly pro-nuclear engineer in a country that passed a referendum officially phasing out nuclear energy since several years before he was born. He has to round up to be…
Westinghouse Sold AP1000 Technology Developed With American Taxpayer Assistance to China More than Three Years Ago
It sometimes surprises me just how long it takes the advertiser supported media to recognize an important story. This morning, my Google News Alert indicated that MSNBC and Bloomberg had both noticed that…
Toshiba Announces $6.3 B Writedown On A $229 M Construction Company Acquisition
Toshiba’s chairman, Shigenori Shiga, has accepted the responsibility for his company’s financial challenges and operating losses and resigned his position as chairman and as a board member. He remains an executive with the…
Reactor Coolant Pumps for AP1000 still a problem
This is a story that I really don’t want to tell, but bad news is like old fish. It doesn’t smell any better as it ages. All eight AP1000 construction projects are at…
Above board competition in energy markets finally emerging. API Ohio pushing for nuclear shutdowns
In a break from its historical tactic of quietly enabling surrogates, the US petroleum industry has started to openly engage in battles to suppress use of atomic fission. The Ohio division of the…
Smoking Gun Part 18 – An Oldie But a Goodie – Oil Heat Institute of Long Island Ad Using Scare Tactics to Fight Shoreham
One of the most famous battles against nuclear energy in the US, a struggle whose effects remain important to this day, was fought on Long Island. The saga involved nearly two decades of…
Smoking gun: LNG ship builders and their financial backers stoke nuclear fears
It’s been a while since my last ‘smoking gun’ report so it might be worth a brief reminder of what that categorization means. For Atomic Insights, the tag ‘smoking gun’ means a story…
Investing in Nuclear
Nuclear investments – enabling the transition to a low-carbon economy

Parnassus Versus Green Century: A Contrast in Styles
Cross-posted from Nucleation Capital June, July and August of 2023 were the three hottest months the Earth has ever seen by such a large margin, it left climate scientists agog. Climate disasters are abounding apace, with the U.S. hit by 23 large-scale disasters, a record-breaking year already. In Pakistan, extreme rainfall and flooding affected 33…

How Hot is Cold Fusion?
The 24th International Conference on Cold Fusion (ICCF24) was held at the lovely and spacious Computer History Museum in Mountain View, CA over four days in late July. As a venture investor looking at evaluating and investing in a wide range of advanced nuclear ventures, I was invited to participate and/or sponsor the event. While…

Rod Adams
Managing Partner, Nucleation Capital, a venture fund enabling broader investor access to a diverse portfolio of advanced nuclear energy and deep decarbonization ventures. Nuclear energy expert and former submarine Engineer Officer with nuclear propulsion plant experience. Founder, Adams Atomic Engines, Inc. Host and producer, The Atomic Show Podcast.